KLRK1 and cancer: Specifically, the inhibition of EHMT2 and TGF-β1 resulted in increased expression of NKG2D ligands (ULBP3 and MICB) on cancer cells in an autocrine manner, resulting in enhanced NK cell-mediated cytotoxicity.